Tag - HLS

Markets

Raymond James ups HLS Therapeutics to OP; PT to $26 (Canadian)

Raymond James upgraded HLS Therapeutics (TSX:HLS) to “outperform” from “market perform” and raised its price target to $26 (Canadian) from $24 after Pfizer agreed to co-market HLS’s cardiovascular drug...

August 16, 2021

Developments

HLS Therapeutics to launch Vascepa in Canada next month

HLS Therapeutics (TSX:HLS) reported that its cardiovascular drug, Vascepa, will be available in Canada on or about February 18, 2020. Vascepa was approved by Health Canada at the end of 2019. HLS noted that the approval...

January 28, 2020

Tag - HLS

Raymond James ups HLS Therapeutics to OP; PT to $26 (Canadian)

HLS Therapeutics to launch Vascepa in Canada next month

General

More